At a Glance
| Methylnaphthidate | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 8–14 mg | 15–30 mg |
| Total Duration | 1.1–2.1 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
Methylnaphthidate, a Stimulants, and 2-FMA, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 23 documented effects in common, with 6 effects unique to Methylnaphthidate and 28 unique to 2-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Methylnaphthidate | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (insufflated) | 8–14 mg | 15–30 mg |
| Total Duration | 1.1–2.1 hrs | 1.5–4 hrs |
| Routes | insufflatedoral | insufflated |
| Effects | 29 documented | 51 documented |
| Level | Methylnaphthidate | 2-FMA |
|---|---|---|
| Threshold | — mg | 5 mg |
| Light | 4–8 mg | 5–15 mg |
| Common | 8–14 mg | 15–30 mg |
| Strong | 14–28 mg | 30–50 mg |
| Heavy | 28 mg | 50 mg |
| Level | Methylnaphthidate | 2-FMA |
|---|---|---|
| Threshold | 4 mg | 5 mg |
| Light | 10–15 mg | 5–15 mg |
| Common | 15–30 mg | 15–30 mg |
| Strong | 30–50 mg | 30–50 mg |
| Heavy | 50 mg | 50 mg |
Methylnaphthidate
2-FMA
Methylnaphthidate
2-FMA
No direct interaction data available between these substances. This does not mean the combination is safe.